PHEXXI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phexxi, and when can generic versions of Phexxi launch?
Phexxi is a drug marketed by Evofem Inc and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.
This drug has sixty-five patent family members in twenty-three countries.
The generic ingredient in PHEXXI is citric acid; lactic acid; potassium bitartrate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the citric acid; lactic acid; potassium bitartrate profile page.
DrugPatentWatch® Generic Entry Outlook for Phexxi
There is one Paragraph IV patent challenge for this drug. This may lead to patent invalidation or a license for generic production.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHEXXI?
- What are the global sales for PHEXXI?
- What is Average Wholesale Price for PHEXXI?
Summary for PHEXXI
International Patents: | 65 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 3 |
Drug Prices: | Drug price information for PHEXXI |
What excipients (inactive ingredients) are in PHEXXI? | PHEXXI excipients list |
DailyMed Link: | PHEXXI at DailyMed |
Recent Clinical Trials for PHEXXI
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Queen's Medical Center | Early Phase 1 |
University of Hawaii Foundation | Early Phase 1 |
Parexel | Phase 3 |
Pharmacology for PHEXXI
Drug Class | Anti-coagulant Calculi Dissolution Agent |
Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
Physiological Effect | Decreased Coagulation Factor Activity |
Paragraph IV (Patent) Challenges for PHEXXI
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PHEXXI | Vaginal Gel | citric acid; lactic acid; potassium bitartrate | 1.8%/1%/0.4% | 208352 | 1 | 2023-02-28 |
US Patents and Regulatory Information for PHEXXI
PHEXXI is protected by five US patents.
Expired US Patents for PHEXXI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Evofem Inc | PHEXXI | citric acid; lactic acid; potassium bitartrate | GEL;VAGINAL | 208352-001 | May 22, 2020 | 6,706,276 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PHEXXI
See the table below for patents covering PHEXXI around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2022070924 | アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法 | ⤷ Subscribe |
Canada | 2402589 | COMPOSITIONS ET PROCEDES PERMETTANT DE PIEGER ET D'INACTIVER LES MICROBES PATHOGENES ET LES SPERMATOZOIDES (COMPOSITIONS AND METHODS FOR TRAPPING AND INACTIVATING PATHOGENIC MICROBES AND SPERMATOZOA) | ⤷ Subscribe |
Australia | 2001243431 | ⤷ Subscribe | |
Mexico | 2021001742 | COMPOSICIONES Y METODOS PARA INHIBIR LA INFLAMACION Y LAS ENFERMEDADES UTILIZANDO UN COMPUESTO ANTIMICROBIANO CON BASE EN ACIDO ALGINICO. (COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING AN ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND.) | ⤷ Subscribe |
New Zealand | 703203 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | ⤷ Subscribe |
China | 106029078 | 使用基于藻酸的抗微生物化合物抑制炎症和疾病的组合物和方法 (Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound) | ⤷ Subscribe |
Japan | 2020125298 | アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法 (COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES BY USING ALGINIC ACID-BASED ANTIMICROBIAL COMPOUNDS) | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
PHEXXI Market Analysis and Financial Projection Experimental
More… ↓